TrialA Phase 3 Study of NE3107 in Probable Alzheimer's Disease
Trial details
- Registry ID
- NCT04669028
- Phase
- Phase 3
Drug research
NE3107
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as bezisterim
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseNCT04669028 | BIVI | Phase 3 | Completed | 2023-09-30Actual |
| A Study of NE3107 in Early Parkinson'sNCT06757010 | BIVI | Phase 2 | Completed | 2026-05-01Actual |
| NE3107 in Adults With Neurological Symptoms of Long COVIDNCT06847191 | BIVI | Phase 2 | Completed | 2026-08-06Actual |
A Study of NE3107 in Early Parkinson's
Trial details
- Registry ID
- NCT06757010
- Phase
- Phase 2
NE3107 in Adults With Neurological Symptoms of Long COVID
Trial details
- Registry ID
- NCT06847191
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |